Satisfying the right to health is one of the key contributors to quality of life on our planet. The human species, as all animal species, contract many diseases, which thanks to scientific research can now be controlled and eradicated.
One of the indicators of this continuing battle is the global pharmaceutical market trend. Indeed, this market is in constant growth, expected to reach 1.3 trillion Euro in 2019 (according to WHO).
Naturally, we are all aware of the need for greater commitment, especially in order to ensure access to medical care in the less developed regions of the world as well as among the poor, also those residing in the more developed countries.
The experience acquired by IMA – a company that has always supported those involved in drug research and production – helps us detect healthcare trends, or rather, capture everything we need in order to guide us in designing and producing future IMA automated machines for the pharmaceutical market.
In a word, the evolution in this critical sector is substantially driven by:
Naturally, each pharmaceutical producer is bound to determine its own priorities when devising a strategy for achieving maximum success in the global markets.
We at IMA must follow and anticipate this process, a challenge we fully embrace and are committed to win by listening to customers’ demands and providing unique solutions.
In this evolutionary process, interacting with our customers is essential, and is part of our tradition of success.
Giovanni Pecchioli
Pharma Business CEO